Pinnacle Wealth Management Advisory Group’s Abivax ABVX Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Buy	+1,864	New	+$221K	0.01%	510

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's ABVX Position: Q1 2026 in Review

Pinnacle Wealth Management Advisory Group opened a new position in Abivax (ABVX) in Q1 2026: 1,864 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #510 among its holdings.

254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

Pinnacle Wealth Management Advisory Group held 1,864 shares of Abivax worth $208K as of Q1 2026.
Abivax was a new Pinnacle Wealth Management Advisory Group position in Q1 2026.
Abivax made up 0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q1 2026, its #510 holding.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.